Form 13-F position report

LEMAITRE VASCULAR INC

Reported by ProShare Advisors LLC

LMAT CUSIP 525558201 Manager CIK 0001357955

Reported 184,225 shares, down 30,435 (14.2%) from the prior quarter.

Reported value -15.9%; share count -14.2% vs. the prior quarter.

Reduced
% of reported 13F value 0.03% This manager · Q2 2022
Shares 184,225 Quarter-end amount reported
Reported value $8,392,000 Fair value at quarter end
Consecutive quarters held 6 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 10412000
2022-03-31 9975000
2022-06-30 8392000
2022-09-30 8141000
2022-12-31 9033174
2023-03-31 9631221
2023-06-30 8619241
2023-09-30 7653079
2023-12-31 8143244
2024-03-31 7559133
2024-06-30 7915583
2024-09-30 7734487
2024-12-31 7570222
2025-03-31 7700593
2025-06-30 6566099
2025-09-30 5925041
2025-12-31 6010320
2026-03-31 6656969
2026-06-30 7225883
2026-09-30 8471340

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for LEMAITRE VASCULAR INC held by ProShare Advisors LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 102,571 +27,270 (36.2%) 0.01% $8,471,340 2026-10-28
Q2 2026 Added 75,301 +14,323 (23.5%) 0.01% $7,225,883 2026-08-11
Q1 2026 Reduced 60,978 -13,132 (-17.7%) < 0.01% $6,656,969 2026-04-27
Q4 2025 Added 74,110 +6,403 (9.5%) 0.01% $6,010,320 2026-02-06
Q3 2025 Reduced 67,707 -11,355 (-14.4%) 0.01% $5,925,041 2025-11-06
Q2 2025 Reduced 79,062 -12,721 (-13.9%) 0.01% $6,566,099 2025-08-07
Q1 2025 Added 91,783 +9,623 (11.7%) 0.02% $7,700,593 2025-05-08
Q4 2024 Reduced 82,160 -1,105 (-1.3%) 0.02% $7,570,222 2025-02-14
Q3 2024 Reduced 83,265 -12,938 (-13.4%) 0.02% $7,734,487 2024-11-14
Q2 2024 Reduced 96,203 -17,708 (-15.5%) 0.02% $7,915,583 2024-08-13
Q1 2024 Reduced 113,911 -29,557 (-20.6%) 0.02% $7,559,133 2024-05-08
Q4 2023 Added 143,468 +2,993 (2.1%) 0.02% $8,143,244 2024-02-14
Q3 2023 Added 140,475 +12,365 (9.7%) 0.02% $7,653,079 2023-11-13
Q2 2023 Reduced 128,110 -59,013 (-31.5%) 0.02% $8,619,241 2023-08-10
Q1 2023 Reduced 187,123 -9,165 (-4.7%) 0.03% $9,631,221 2023-05-12
Q4 2022 Added 196,288 +35,659 (22.2%) 0.03% $9,033,174 2023-02-02
Q3 2022 Reduced 160,629 -23,596 (-12.8%) 0.03% $8,141,000 2022-11-07
Q2 2022 Reduced 184,225 -30,435 (-14.2%) 0.03% $8,392,000 2022-08-01
Q1 2022 Added 214,660 +7,389 (3.6%) 0.02% $9,975,000 2022-05-10
Q4 2021 Added 207,271 +43,213 (26.3%) 0.02% $10,412,000 2022-02-08
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

197 managers reported LEMAITRE VASCULAR INC for Q2 2022.

Managers reporting LEMAITRE VASCULAR INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 3,241,096 +65,664 < 0.01% $147,630,000 28 qtrs
Conestoga Capital Advisors LLC Reduced 1,855,786 -24,061 1.54% $84,531,000 22 qtrs
VANGUARD GROUP INC Added 1,453,803 +27,568 < 0.01% $66,221,000 37 qtrs
Copeland Capital Management LLC Reduced 1,212,306 -2,699 1.75% $55,220,000 15 qtrs
Ranger Investment Management L P Added 895,459 +225,033 3.09% $40,788,000 21 qtrs
GENEVA CAPITAL MANAGEMENT LLC Reduced 856,779 -10,038 0.9% $39,027,000 10 qtrs
STATE STREET CORPORATION Added 754,066 +44,301 < 0.01% $34,348,000 29 qtrs
DIMENSIONAL FUND ADVISORS LP Reduced 680,540 -8,707 0.01% $30,998,000 37 qtrs
CRAMER ROSENTHAL MCGLYNN LLC New 461,403 +461,403 0.97% $21,017,000 1 qtr
GEODE CAPITAL MANAGEMENT LLC Added 385,335 +33,900 < 0.01% $17,552,000 37 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 01, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
184,225
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.